SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kloner, R. A.
Right arrow Articles by Bhandari, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kloner, R. A.
Right arrow Articles by Bhandari, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Postconditioning Markedly Attenuates Ventricular Arrhythmias After Ischemia-Reperfusion

Robert A. Kloner, MD, PhD

Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA; Heart Institute, Good Samaritan Hospital, 1225 Wilshire Boulevard, Los Angeles, CA 90017; rkloner{at}goodsam.org

Joan Dow, BS

Anil Bhandari, MD

Heart Institute, Good Samaritan Hospital, Keck School of Medicine, University of Southern California, Los Angeles, CA

Background: Brief periods of reocclusion (postconditioning) during early reperfusion reduce myocardial infarct size. Whether postconditioning has an effect on lethal ventricular arrhythmias independent of infarction in an in-vivo regional ischemia model is unknown. The purpose of this study was to determine if postconditioning limited reperfusion arrhythmias in a necrosis-free model.

Methods: Anesthetized rats were subjected to 5 minutes of proximal coronary artery occlusion; they were randomized to a control group (n = 15) that underwent reperfusion alone or a postconditioning group (n = 15) that received four cycles of 20 seconds reperfusion, 20 seconds reocclusion before final reperfusion.

Results: During the final reperfusion phase, ventricular arrhythmias occurred in 14 of 15 control rats and 8 of 15 postconditioning rats (P = .017). Ventricular tachycardia occurred in 10 of 15 control rats vs 4 of 15 postconditioning rats (P = .028). Control rats demonstrated 1.3 runs of ventricular tachycardia per minute vs 0.4 runs in postconditioning rats (P = .026). The average duration of ventricular tachycardia runs was 8.8 ± 3.2 seconds in the control group vs 5.0 ± 3.9 seconds in postconditioning rats (P = NS).

Conclusion: This in-vivo study showed that postconditioning markedly attenuates ventricular arrhythmia after regional ischemia in a noninfarct model.

Key Words: ischemia-reperfusion • postconditioning • ventricular tachycardia

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 11, No. 1, 55-63 (2006)
DOI: 10.1177/107424840601100105


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. K. Dhalla, W.-Q. Wang, J. Dow, J. C. Shryock, L. Belardinelli, A. Bhandari, and R. A. Kloner
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1923 - H1929.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
E. Golomb, A. Nyska, and H. Schwalb
Occult Cardiotoxicity--Toxic Effects on Cardiac Ischemic Tolerance
Toxicol Pathol, August 1, 2009; 37(5): 572 - 593.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Granfeldt, D. J. Lefer, and J. Vinten-Johansen
Protective ischaemia in patients: preconditioning and postconditioning
Cardiovasc Res, July 15, 2009; 83(2): 234 - 246.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Dow, A. Bhandari, and R. A. Kloner
The Mechanism by Which Ischemic Postconditioning Reduces Reperfusion Arrhythmias in Rats Remains Elusive
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 99 - 103.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Dow, A. Bhandari, and R. A. Kloner
Ischemic Postconditioning's Benefit on Reperfusion Ventricular Arrhythmias Is Maintained in the Senescent Heart
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 141 - 148.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Hale, A. Mehra, J. Leeka, and R. A. Kloner
Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H421 - H425.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson
Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury
J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Gomez, H. Thibault, A. Gharib, J.-M. Dumont, G. Vuagniaux, P. Scalfaro, G. Derumeaux, and M. Ovize
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1654 - H1661.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Dow and R. A. Kloner
Postconditioning Does Not Reduce Myocardial Infarct Size in an In Vivo Regional Ischemia Rodent Model
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 153 - 163.
[Abstract] [PDF]


Home page
Eur Heart JHome page
R. A. Kloner, M. B. Forman, R. J. Gibbons, A. M. Ross, R. W. Alexander, and G. W. Stone
Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial
Eur. Heart J., October 2, 2006; 27(20): 2400 - 2405.
[Abstract] [Full Text] [PDF]



Advertisement